CTBE Initiates Randomized Controlled Cohort in Corporate Clinical Trial for Knee Anterior Cruciate Ligament Reconstruction Treatment
CoreTissue BioEngineering (CTBE) has announced the completion of the safety evaluation cohort and th… · 2026-05-11
CoreTissue BioEngineering (CTBE) has announced the completion of the safety evaluation cohort and th… · 2026-05-11
CoreTissue BioEngineering (CTBE) has announced the completion of the safety evaluation cohort and th… · 2026-05-11